Why Does Acute Post Whiplash Injury Pain Transform Into Chronic Pain?

NCT ID: NCT02560675

Last Updated: 2024-04-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

399 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-01-31

Study Completion Date

2021-09-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Why does acute post whiplash injury pain transform into chronic pain? Multi-modal assessment of risk factors and predictors of pain chronification

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Background

The proposed study aims to explore why acute pain turns, in some patients, into chronic pain, and to develop tools for prediction of this transition. Based on the clinical and psychological assessment along with psychophysical and neurophysiological assessment of pain perception, with the analysis of connectivity between several brain centers relevant for pain processing, together with pain genetics, we expect to develop a tool, that will predict, for the individual patient with acute pain inflicted by a whiplash injury, what are the chances for him/her to go into chronic pain situation. Further, by knowing the dysfunctions of pain processing that a patient has, it will be possible to offer the treatment of highest chances to succeed.

Our specific aims are to evaluate, in the setup of acute whiplash injury, the risk of transition to chronic pain based on each of the following testing domains: (i) Psychophysical and neurophysiological data describing facilitatory and inhibitory modulation capacity of the patient. (ii) Psychological data describing patient's behavior such as catastrophizing, fear of pain, post-traumatic stress and depressed mood. (iii) Structural and functional neuro-imaging data describing brain anatomy and function, where we assess resting state MRI activity, grey matter properties using T1 weighted imaging, and white matter properties using diffusion tensor imaging. (iv) Genetic data describing the genetic epidemiology of every patient for the examination of genetic variants associated with transition to chronic pain, and (v) individual case data related to age, gender, education, socioeconomic parameters and personal medical history, as well as features of the specific injury. Overall, we aim to construct a composite scoring system, based on the most relevant of the above mentioned parameters, yielding the highest relative predictive value in identifying acute pain patients who have higher risk for chronification.

Subjects One hundred and twenty healthy subjects (range 20-79; 20 subjects per age decade, 10 M and 10 F) will participate in the first phase of the study aimed to collect normative data from healthy population.

Seven hundred and fifty acute whiplash-injury based mild traumatic brain injuries (TBI) will participate in this study.

Study design Phase I - Normative data collection for the inhibitory and excitatory pain modulation responses, a study on healthy subjects

Phase II - Multi-modal assessment of acute mild TBI whiplash patients and follow-up

1. Initial experimental assessment, will consist, in most cases, of two sessions, one during the ER visit, and the next within 72 hrs of injury, pending on team and device availability, such that all tests will be completed, as follows:

1. Physical examination with a full neurological exam, and assessment of neck movement.
2. Psychophysical pain measurements:

i. Pain thresholds. ii. Suprathreshold pain magnitude estimation; iii. Mechanical temporal summation (TS) and electrical TS iv. Conditioned pain modulation (CPM) - as described for the phase I protocol. It is noted that similar protocols of pain measurement are commonly performed in many labs worldwide in many acute and chronic pain setups, and are considered safe, with no damaging effect on the disease state.

c. Psychological examination via filling questionnaires for evaluation the following variables: i. Pain Catastrophizing ii. Depression iii. Post-traumatic Diagnostic Scale (PDS) iv. Fear of pain v. The perceived stress of the subjects is assessed by the validated Hebrew version Cohen's Perceived Stress Scale (PSS).

vi. Five factor model (FFM)

d.Blood collection for genetics. Whole blood sample (10cc) will be collected from each subject and placed in Ethylenediaminetetraacetic acid (EDTA)-coated tubes. Genomic DNA will be isolated using DNA Extraction Kit . Quality and quantity of the DNA sample will be measured using a NanoDrop Machine.

e. Magnetic resonance imaging (MRI)/Functional MRI (fMRI) examination in a 3T scanner.

f. Neurophysiological assessment of pain modulation with 64-channel EEG recording (Brain Products GmbH, Munich, Germany) of CPM and TS.

i.Neurophysiological assessment of CPM ii.Neurophysiological assessment of TS will be based on electrical evoked potentials obtained with a constant current stimulator
2. Follow up Patients will self-report their pain levels and use of analgesics once in two weeks.

At 6 and 12 month visits patients will be invited to repeat the psychophysical and neurophysiological pain assessments and psychological questionnaires. Selected patients will undergo a second MRI assessment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Pain Due to Injury

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

120 healthy subjects

One hundred and twenty healthy subjects (range 20-79; 20 subjects per age decade, 10 M and 10 F) will participate in the first phase of the study aimed to collect normative data from healthy population.

Study design Phase I - Normative data collection for the inhibitory and excitatory pain modulation responses, a study on healthy subjects (no blood tests)

No interventions assigned to this group

750 subjects with acute whiplash-injury

Seven hundred and fifty acute whiplash-injury based mild TBI will participate in this study.

Phase II - Multi-modal assessment of acute mild TBI whiplash patients and follow-up

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Diagnosis of whiplash injured in road accident up to 72h before ER arrival; Glasgow coma scale 13-15 and no traumatic brain findings in computed tomography (CT); no, or shorter than 30 minutes loss of consciousness in the accident. Age 18-70, both males and females.

Exclusion Criteria

Other major bodily injuries at present accident; intracranial hemorrhage or skull fracture in present accident, prior chronic head/neck pain that requires treatment on regular basis; neurological disease that might affect performance of the tests or their interpretation such as neurodegenerative diseases; head and neck injury in past year.
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Technion, Israel Institute of Technology

OTHER

Sponsor Role collaborator

Congressionally Directed Medical Research Programs

FED

Sponsor Role collaborator

Rambam Health Care Campus

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

David Yarnitsky

Role: PRINCIPAL_INVESTIGATOR

Head of Neurology department at Rambam

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Rambam Health Care Campus

Haifa, , Israel

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Israel

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

597-14-RMB Gene_Whiplash_CTIL

Identifier Type: OTHER

Identifier Source: secondary_id

601-14-RMB Whiplash_CTIL

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Pain Related Variables
NCT06007443 COMPLETED NA